Masteron and Sermorelin Interaction

Monitor
Mechanism-based 47% confidence

Masteron and Sermorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Masteron and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. These compounds primarily affect different organ systems.

Compound Profiles

Masteron

DHT-Derived Anabolic Steroid | Hardening & Anti-Estrogenic

Drostanolone binds to the androgen receptor with high affinity, promoting protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, eliminating estrogen-related side effects such as water retention and gynecomastia from the compound itself.

Half-life: ~2 days (propionate), ~10 days (enanthate) Typical dose: 300-500 mg/week anabolic
androgen receptoraromataseestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Sermorelin

GHRH Analog | Growth Hormone Releasing Hormone

Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..

Half-life: 10-12 minutes Typical dose: 200-300mcg per dose (up to 500mcg for athletic performance) growth hormone, weight loss
estrogen receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Liver
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Masteron, Sermorelin). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Masteron, Sermorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Masteron with Sermorelin?

Yes, but with caution. Both Masteron and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Regular monitoring is advised.

Is Masteron and Sermorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between Masteron and Sermorelin?

Both Masteron and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Masteron and Sermorelin?

Masteron has a half-life of ~2 days (propionate), ~10 days (enanthate) and Sermorelin has a half-life of 10-12 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Masteron vs Sermorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.